Skip to main content

RheumNow Podcast – Up, Down & Turned Around (12.18.20)

Dr Jack Cush reviews the news and journal articles from this past week on RheumNow.com

  1. Global Burden of Disease study published in Arthritis & Rheumatology, shows that in 2017 there were 1.3 billion cases of musculoskeletal disorders worldwide, leading to 121,300 deaths and 138.7 million disability adjusted life years https://bit.ly/3mmKtbH

  2. Encouraging Rheumatology Fellowship Match for 2021

  3. Phase III RHAPSODY trial: open label rilonacept in 86 pts with active recurrent pericarditis (& elevated CRP). Rapid resolution was noted and during the drug withdrawal phase there were significantly fewer recurrences on rilonacept compared with placebo. https://bit.ly/3agohO1

  4. NHANES study shows Peripheral neuropathy (11.6-13.5% population) was common and was independently associated with significant increase in all cause mortality (31-49% increased) in the U.S. population, even in the absence of diabetes. https://bit.ly/3qU3WEh

  5. Benlysta First Agent Approved for Lupus Nephritis

  6. Filgotinib Bows Out of the RA Race in the USA

  7. Checkout Dr. Kevin Winthrops RheumNow interview for insights and caveats on the use of COVID-19 vaccination in patients with rheumatic disease and those taking biologics or DMARDs. To hold MTX or not? https://bit.ly/38godLK

  8. ACIP Recommendations for Pfizer-BioNTech COVID-19 Vaccine Use (including Special Populations)

  9. Amer. College OBGYN practice advisory states women who are Pregnant or lactating should be offered COVID-19 vaccines. These vaccines have not been tested in pregnant women & a pregnancy test is not required to receive the vaccine https://bit.ly/2Kt7Tz5

  10. COVID Risks in Systemic Autoimmune Patients 

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

Disclosures
The author has received compensation as an advisor or consultant on this subject
×